FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069682711> ?p ?o ?g. }

• W2069682711 endingPage "166" @default.
• W2069682711 startingPage "156" @default.
• W2069682711 abstract "Idiopathic inflammatory bowel disease (IBD) in dogs can be challenging to diagnose and fecal markers of disease that correlate with its severity could potentially be clinically useful. Surrogate inflammatory markers, such as the concentration of fecal S100A12, are used to detect active IBD in humans. The aim of this study was to determine the relationship between fecal canine S100A12 concentrations and clinical, endoscopic, and histologic disease severity. Twenty-six dogs with IBD and 90 healthy control dogs were enrolled. Spot fecal samples were collected and fecal canine S100A12 concentrations measured by an in-house ELISA. The correlation of fecal canine S100A12 concentrations with clinical disease activity (using the canine chronic enteropathy clinical activity index scoring system) and with endoscopic and histologic disease severity (using semi-quantitative grading systems) was assessed in dogs with IBD. Concentrations of fecal canine S100A12 were significantly higher in dogs with IBD (median [interquartile range]: 223 [21–3477] ng/g) than in healthy controls (median [interquartile range]: 9 [5–31] ng/g; P < 0.0001). Fecal canine S100A12 concentrations correlated with the CCECAI score (ρ = 0.4778; P = 0.0408) and the severity of endoscopic lesions in the duodenum (ρ = 0.4703; P = 0.0354) and colon (ρ = 0.9747; P = 0.0144), but not with the severity of histopathologic changes except for inflammatory lesions in the colon (ρ = 0.8669; P = 0.0230). A concentration of 273 ng fecal canine S100A12/g feces or greater distinguished (a) dogs with moderate to severe endoscopic disease in any GI section from dogs with at most mild endoscopic disease, and (b) dogs with very severe clinical disease (i.e., a CCECAI score of ≥12) from dogs with a CCECAI score of <12, with a sensitivity of 71% and 90%, respectively, and a specificity of 89% and 75%, respectively. This study showed that fecal canine S100A12 concentrations are increased in dogs with IBD. Further, this study showed that fecal canine S100A12 is associated with the clinical disease activity, the severity of endoscopic lesions, and the severity of colonic inflammation in dogs with IBD. Fecal S100A12 concentrations are potentially useful as a biomarker of inflammation in dogs with IBD." @default.
• W2069682711 created "2016-06-24" @default.
• W2069682711 creator A5001684704 @default.
• W2069682711 creator A5002194131 @default.
• W2069682711 creator A5012230637 @default.
• W2069682711 creator A5017199731 @default.
• W2069682711 creator A5018799234 @default.
• W2069682711 creator A5023330965 @default.
• W2069682711 creator A5028655640 @default.
• W2069682711 creator A5040938903 @default.
• W2069682711 creator A5062945808 @default.
• W2069682711 creator A5073922918 @default.
• W2069682711 creator A5078185248 @default.
• W2069682711 date "2014-04-01" @default.
• W2069682711 modified "2023-10-14" @default.
• W2069682711 title "Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease" @default.
• W2069682711 cites W1592771441 @default.
• W2069682711 cites W1880127774 @default.
• W2069682711 cites W1970975959 @default.
• W2069682711 cites W1987489268 @default.
• W2069682711 cites W1990867814 @default.
• W2069682711 cites W1996313175 @default.
• W2069682711 cites W2001822779 @default.
• W2069682711 cites W2003939487 @default.
• W2069682711 cites W2013826174 @default.
• W2069682711 cites W2016219300 @default.
• W2069682711 cites W2022262919 @default.
• W2069682711 cites W2040580506 @default.
• W2069682711 cites W2042294616 @default.
• W2069682711 cites W2046230132 @default.
• W2069682711 cites W2050093406 @default.
• W2069682711 cites W2071675524 @default.
• W2069682711 cites W2074280408 @default.
• W2069682711 cites W2084672610 @default.
• W2069682711 cites W2109334664 @default.
• W2069682711 cites W2130811238 @default.
• W2069682711 cites W2134643141 @default.
• W2069682711 cites W2148439360 @default.
• W2069682711 cites W2151219999 @default.
• W2069682711 cites W2157222645 @default.
• W2069682711 cites W2159111033 @default.
• W2069682711 cites W2167770260 @default.
• W2069682711 cites W2168985716 @default.
• W2069682711 cites W4245277907 @default.
• W2069682711 doi "https://doi.org/10.1016/j.vetimm.2014.01.006" @default.
• W2069682711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24518653" @default.
• W2069682711 hasPublicationYear "2014" @default.
• W2069682711 type Work @default.
• W2069682711 sameAs 2069682711 @default.
• W2069682711 citedByCount "42" @default.
• W2069682711 countsByYear W20696827112014 @default.
• W2069682711 countsByYear W20696827112015 @default.
• W2069682711 countsByYear W20696827112016 @default.
• W2069682711 countsByYear W20696827112017 @default.
• W2069682711 countsByYear W20696827112018 @default.
• W2069682711 countsByYear W20696827112019 @default.
• W2069682711 countsByYear W20696827112020 @default.
• W2069682711 countsByYear W20696827112021 @default.
• W2069682711 countsByYear W20696827112022 @default.
• W2069682711 countsByYear W20696827112023 @default.
• W2069682711 crossrefType "journal-article" @default.
• W2069682711 hasAuthorship W2069682711A5001684704 @default.
• W2069682711 hasAuthorship W2069682711A5002194131 @default.
• W2069682711 hasAuthorship W2069682711A5012230637 @default.
• W2069682711 hasAuthorship W2069682711A5017199731 @default.
• W2069682711 hasAuthorship W2069682711A5018799234 @default.
• W2069682711 hasAuthorship W2069682711A5023330965 @default.
• W2069682711 hasAuthorship W2069682711A5028655640 @default.
• W2069682711 hasAuthorship W2069682711A5040938903 @default.
• W2069682711 hasAuthorship W2069682711A5062945808 @default.
• W2069682711 hasAuthorship W2069682711A5073922918 @default.
• W2069682711 hasAuthorship W2069682711A5078185248 @default.
• W2069682711 hasBestOaLocation W20696827112 @default.
• W2069682711 hasConcept C119060515 @default.
• W2069682711 hasConcept C126322002 @default.
• W2069682711 hasConcept C142724271 @default.
• W2069682711 hasConcept C151730666 @default.
• W2069682711 hasConcept C2778260677 @default.
• W2069682711 hasConcept C2778292693 @default.
• W2069682711 hasConcept C2779134260 @default.
• W2069682711 hasConcept C30036603 @default.
• W2069682711 hasConcept C61716771 @default.
• W2069682711 hasConcept C71924100 @default.
• W2069682711 hasConcept C86803240 @default.
• W2069682711 hasConcept C90924648 @default.
• W2069682711 hasConceptScore W2069682711C119060515 @default.
• W2069682711 hasConceptScore W2069682711C126322002 @default.
• W2069682711 hasConceptScore W2069682711C142724271 @default.
• W2069682711 hasConceptScore W2069682711C151730666 @default.
• W2069682711 hasConceptScore W2069682711C2778260677 @default.
• W2069682711 hasConceptScore W2069682711C2778292693 @default.
• W2069682711 hasConceptScore W2069682711C2779134260 @default.
• W2069682711 hasConceptScore W2069682711C30036603 @default.
• W2069682711 hasConceptScore W2069682711C61716771 @default.
• W2069682711 hasConceptScore W2069682711C71924100 @default.
• W2069682711 hasConceptScore W2069682711C86803240 @default.
• W2069682711 hasConceptScore W2069682711C90924648 @default.
• W2069682711 hasIssue "3-4" @default.

• next